Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

PACIRA BIOSCIENCES, INC.

(PCRX)
  Report
Real-time Estimate Cboe BZX  -  02:20 2022-11-28 pm EST
49.18 USD   -1.04%
11/15Sector Update: Health Care Stocks Edge Higher Premarket Tuesday
MT
11/15Pacira BioSciences Reports Higher Exparel Preliminary Net Product Sales in October; Wedbush Maintains Forecast
MT
11/14Pacira BioSciences Reports Higher Exparel Preliminary Net Product Sales in October
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Days
:
Hours
:
Minutes
:
Seconds
Business Summary
Logo Pacira BioSciences, Inc.
Pacira BioSciences, Inc. is a holding company for Pacira Pharmaceuticals, Inc. The Company is engaged in advancing a pipeline of products across a range of therapeutic areas that include acute postsurgical pain; acute and chronic osteoarthritis (OA), pain of the knee; low back and other areas; spasticity and stellate ganglion block of the sympathetic nerves. The company is developing interventions to address debilitating conditions involving the sympathetic nervous system. The Company's non-opioid treatments include EXPAREL (bupivacaine liposome injectable suspension), which is a long-acting, local analgesic; ZILRETTA (triamcinolone acetonide extended-release injectable suspension), which is an extended-release, intra-articular, corticosteroid injection indicated for OA knee pain, and Iovera, which is a novel handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

Number of employees : 697 people.
Sales per Business
20202021Delta
EXPAREL413.3496.2%506.5293.5% +22.54%
Iovera8.822.1%16.163% +83.3%
ZILRETTA--12.682.3%-
Bupivacaine Liposome Injectable Suspension4.461%3.610.7% -19.13%
Royalty3.030.7%2.440.5% -19.49%
Collaborative Licensing and Milestone Revenue--0.13--
USD in Million
Sales per region
20202021Delta
United States429.65100%541.53100% +26.04%
USD in Million
Managers
Name Title Age Since
David M. Stack Chairman & Chief Executive Officer 69 2022
Charles A. Reinhart Chief Financial Officer 60 2016
Roy Winston, Dr. Chief Medical Officer 60 -
Charles Anthony Laranjeira Senior Vice President-Technical Operations 55 2017
Jonathan Slonin, Dr. Chief Clinical Officer 46 2021
Daryl J. Gaugler Chief Operating Officer 59 2022
Anthony Molloy Chief Legal & Compliance Officer 47 -
Kristen Marie Williams Secretary & Chief Administrative Officer 47 2014
Susan Mesco Investor Relations Contact - 2015
Lauren Bullaro Riker Vice President-Finance 42 -
Members of the board
Name Title Age Since
David M. Stack Chairman & Chief Executive Officer 69 2022
Andreas Wicki, Dr. Independent Director 62 2006
Gary W. Pace, Dr. Independent Director 73 2008
Laura A. Brege Independent Director 63 2011
Paul J. Hastings Lead Independent Director 61 2013
Mark A. Kronenfeld, Dr. Independent Director 66 2013
Yvonne Greenstreet Independent Director 59 2014
Mark I. Froimson, Dr. Independent Director 60 2017
Christopher J. Christie Director 58 2019
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 45,882,088 45,354,573 98.9% 0 0.0% 98.9%
Shareholders
NameEquities%
The Vanguard Group, Inc. 4,697,430 10.3%
Macquarie Investment Management Business Trust 3,562,832 7.78%
Consonance Capital Management LP 2,799,916 6.11%
Visium Asset Management LP 2,239,098 4.89%
Renaissance Technologies LLC 1,965,497 4.29%
Baillie Gifford & Co. 1,847,797 4.03%
SSgA Funds Management, Inc. 1,654,473 3.61%
Avoro Capital Advisor LLC 1,600,000 3.49%
Spyglass Capital Management LLC 1,460,634 3.19%
Loomis, Sayles & Co. LP 1,285,829 2.81%
Brand Portfolio
In partnership withAllbrands.markets
More brands of Pacira BioSciences, Inc.
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
PACIRA BIOSCIENCES, INC.-17.42%2 280
JOHNSON & JOHNSON3.61%463 391
ELI LILLY AND COMPANY32.23%347 052
ABBVIE INC.17.89%282 189
PFIZER, INC.-16.66%276 231
MERCK & CO., INC.40.27%272 555
ROCHE HOLDING AG-17.86%270 482
NOVO NORDISK A/S15.51%268 222
ASTRAZENECA PLC26.23%205 164
NOVARTIS AG3.43%188 707
BRISTOL-MYERS SQUIBB COMPANY27.09%175 885
AMGEN INC.26.12%151 398
SANOFI-1.17%114 152
GILEAD SCIENCES, INC.18.80%108 191
GSK PLC-15.28%68 136
DAIICHI SANKYO CO., LTD.57.03%63 245
BAYER AG17.98%56 645
TAKEDA PHARMACEUTICAL COMPANY LIMITED28.63%45 057
CHUGAI PHARMACEUTICAL CO., LTD-2.78%42 904
JIANGSU HENGRUI MEDICINE CO., LTD.-21.85%35 249
ASTELLAS PHARMA INC.14.68%28 081